The quarter's performance reflects a company navigating the complexities of revenue growth against margin headwinds, with employee costs rising to ₹2,223.92 crores whilst operating profit margins contracted. Perhaps more significantly, the shareholding pattern revealed a dramatic 9.51 percentage point sequential decline in promoter holding from 40.10% to 30.59%, coinciding with aggressive institutional accumulation by mutual funds, which increased their stake by 6.25 percentage points to 30.66%. The stock closed at ₹2,454.05 on February 13, 2026, down 0.43% on the day, reflecting investor caution following the results announcement.
Financial Performance: Revenue Momentum Meets Margin Compression
Mphasis demonstrated robust topline momentum in Q3 FY26, with net sales reaching ₹4,002.58 crores, representing sequential growth of 2.58% and year-on-year expansion of 12.39%. This marked the seventh consecutive quarter of sequential revenue growth, with the company achieving its highest-ever quarterly revenue. However, the revenue strength was undermined by deteriorating profitability metrics across the board.
| Quarter | Revenue (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth | Operating Margin | PAT Margin |
|---|---|---|---|---|---|---|
| Dec'25 | 4,002.58 | +2.58% | 442.19 | -5.73% | 18.78% | 11.05% |
| Sep'25 | 3,901.91 | +4.54% | 469.07 | +6.20% | 18.54% | 12.02% |
| Jun'25 | 3,732.49 | +0.61% | 441.70 | -1.07% | 18.83% | 11.83% |
| Mar'25 | 3,710.04 | +4.18% | 446.49 | +4.37% | 18.94% | 12.03% |
| Dec'24 | 3,561.34 | +0.71% | 427.81 | +1.06% | 19.04% | 12.01% |
| Sep'24 | 3,536.15 | +3.32% | 423.33 | +4.65% | 18.32% | 11.97% |
| Jun'24 | 3,422.46 | — | 404.51 | — | 18.07% | 11.82% |
The margin compression story emerged as the quarter's most concerning development. Operating profit (PBDIT) excluding other income stood at ₹751.68 crores, the highest quarterly figure on record, but the operating margin of 18.78% remained below the 19.04% achieved in the year-ago quarter. More troubling was the sequential deterioration in PAT margin from 12.02% in Q2 FY26 to 11.05% in Q3 FY26, a decline of 97 basis points that signals intensifying cost pressures.
Employee costs, the largest expense line for IT services companies, rose to ₹2,223.92 crores in Q3 FY26, though this represented a marginal sequential decline from ₹2,242.69 crores in Q2 FY26. On a year-on-year basis, employee costs surged 11.81%, slightly below the revenue growth rate of 12.39%, suggesting some operational leverage. However, the absolute increase of ₹234.92 crores in employee costs year-on-year consumed a significant portion of the revenue gains, limiting margin expansion potential.
Operational Challenges: The Margin Dilemma Deepens
The company's operational performance in Q3 FY26 highlighted a fundamental challenge facing mid-tier IT services providers: sustaining margin expansion whilst investing in growth capabilities. Mphasis achieved its highest quarterly operating profit (PBDIT) excluding other income at ₹751.68 crores, yet the margin profile deteriorated both sequentially and year-on-year, raising questions about pricing power and cost management effectiveness.
Margin Pressure: Key Concerns
Operating Margin Contraction: The operating margin (excluding other income) of 18.78% in Q3 FY26 marked a 26 basis point decline from 19.04% in Q3 FY25, despite revenue growth of 12.39%. This suggests that cost inflation, particularly in employee expenses, is outpacing pricing improvements and productivity gains.
PAT Margin Deterioration: The profit after tax margin compressed sharply to 11.05% from 12.02% in the previous quarter, a 97 basis point sequential decline that reflects the cumulative impact of operational deleverage, higher interest costs, and elevated depreciation charges.
Return on equity, a critical measure of capital efficiency, stood at 20.32% on an average basis over recent years, demonstrating solid profitability relative to shareholder capital deployed. The latest ROE of 18.55% indicates some moderation in capital efficiency, though the metric remains healthy by industry standards. Return on capital employed (ROCE) averaged 29.84% over the measurement period, with the latest figure at 25.39%, suggesting declining returns on the capital base as the company invests in growth infrastructure.
The balance sheet remained debt-free with zero long-term borrowings as of March 2025, positioning Mphasis as a net cash company with a negative net debt to equity ratio of -0.07. Shareholder funds stood at ₹9,628.40 crores, reflecting steady capital accumulation, whilst fixed assets increased to ₹5,137.01 crores, indicating ongoing investment in infrastructure and capabilities. Current assets of ₹6,986.12 crores provided comfortable liquidity coverage against current liabilities of ₹4,448.71 crores.
Industry Context: Mid-Tier IT Services Under Margin Pressure
The Indian IT services sector has witnessed divergent performance trajectories in FY26, with large-cap players benefiting from scale advantages and vendor consolidation trends, whilst mid-tier companies like Mphasis face intensifying competition for talent and projects. The company's 5-year sales growth of 9.97% and EBIT growth of 8.77% reflect steady but unspectacular expansion, lagging the industry's growth leaders who have achieved double-digit CAGR over the same period.
Mphasis operates in a segment characterised by moderate growth but intense margin pressures. The company's employee cost ratio has remained elevated, reflecting competitive talent markets and wage inflation, whilst pricing power has been constrained by client budget pressures and the commoditisation of certain service offerings. The company's ability to navigate these headwinds through operational efficiency improvements and portfolio mix optimisation will determine its competitive positioning in coming quarters.
Demand Environment: Mixed Signals
The IT services demand environment remains characterised by cautious client spending, with discretionary project approvals delayed as enterprises navigate macroeconomic uncertainty. Mphasis's revenue growth of 12.39% year-on-year in Q3 FY26 outpaced the broader industry's mid-single-digit growth, suggesting some market share gains or portfolio strength in specific verticals. However, the sequential revenue growth of 2.58% indicates moderating momentum compared to the 4.54% sequential expansion achieved in Q2 FY26.
Peer Comparison: Valuation Discount Reflects Margin Concerns
Mphasis trades at a price-to-earnings ratio of 25.63x on a trailing twelve-month basis, representing a discount to peers such as LTI Mindtree (29.29x), Tech Mahindra (31.12x), and Coforge (35.52x), though commanding a premium to Wipro (16.95x). The valuation discount relative to higher-quality peers reflects investor concerns about margin sustainability and growth trajectory, whilst the premium to Wipro acknowledges superior return on equity and operational efficiency.
| Company | P/E (TTM) | ROE (%) | P/BV | Div Yield (%) | Debt/Equity |
|---|---|---|---|---|---|
| Mphasis | 25.63 | 20.32 | 4.86 | 2.32 | -0.07 |
| Wipro | 16.95 | 16.48 | 2.63 | 5.13 | -0.41 |
| LTI Mindtree | 29.29 | 26.97 | 6.49 | 1.31 | -0.42 |
| Tech Mahindra | 31.12 | 16.46 | 5.46 | 2.93 | -0.19 |
| Persistent Systems | 47.99 | 21.92 | 12.09 | 0.67 | -0.20 |
| Coforge | 35.52 | 19.88 | 6.64 | 1.16 | 0.06 |
Mphasis's return on equity of 20.32% positions it in the middle of the peer group, superior to Wipro (16.48%) and Tech Mahindra (16.46%) but trailing LTI Mindtree's impressive 26.97%. The company's price-to-book ratio of 4.86x reflects a moderate valuation relative to the quality of the underlying business, with the metric suggesting investors are willing to pay approximately five times book value for Mphasis's earnings power and growth prospects.
The dividend yield of 2.32% provides some income cushion for investors, comparing favourably to most peers except Wipro's generous 5.13% yield. Mphasis's dividend payout ratio of 63.65% indicates a shareholder-friendly capital allocation policy, though it leaves limited room for payout increases without compromising growth investments or balance sheet strength.
Valuation Analysis: Premium Justified by Quality, But Growth Concerns Loom
At the current market price of ₹2,454.05, Mphasis trades at a price-to-earnings ratio of 26x, representing a premium to the broader IT services sector average of 24x. This valuation multiple reflects the company's debt-free balance sheet, consistent profitability, and solid return ratios, but the premium appears increasingly difficult to justify given the margin compression trajectory and moderating growth momentum.
The price-to-earnings-growth (PEG) ratio of 2.52x signals expensive valuation relative to growth prospects, with the metric suggesting investors are paying 2.52 times the company's earnings growth rate for each unit of P/E multiple. A PEG ratio above 2.0 typically indicates overvaluation, particularly concerning given the margin headwinds and flat financial trend classification assigned to the most recent quarter.
The stock's enterprise value to EBITDA multiple of 16.02x and EV to EBIT ratio of 19.70x both reflect premium valuations that embed expectations for margin recovery and accelerated growth. However, with the company classified as "expensive" in the valuation grade assessment since July 2025, these multiples appear stretched relative to near-term fundamentals, suggesting limited upside potential unless operational performance improves materially.
Shareholding Pattern: Dramatic Promoter Stake Reduction Triggers Institutional Reshuffling
The most striking development in Q3 FY26 was the dramatic 9.51 percentage point sequential decline in promoter holding from 40.10% in September 2025 to 30.59% in December 2025. This marked the largest single-quarter reduction in promoter stake in the company's recent history, with Bcp Topco Ix Pte. Ltd. reducing its position significantly. The timing and magnitude of this stake sale raises questions about promoter confidence in near-term prospects and valuation sustainability at current levels.
| Quarter | Promoter (%) | FII (%) | Mutual Funds (%) | Insurance (%) | Other DII (%) |
|---|---|---|---|---|---|
| Dec'25 | 30.59 (▼9.51) | 19.79 (▲1.27) | 30.66 (▲6.25) | 13.76 (▲1.42) | 0.83 (▲0.51) |
| Sep'25 | 40.10 (—) | 18.52 (▼0.48) | 24.41 (▲0.13) | 12.34 (▲0.56) | 0.32 (▼0.12) |
| Jun'25 | 40.10 (▼0.04) | 19.00 (▼1.61) | 24.28 (▲1.33) | 11.78 (▲0.32) | 0.44 (▼0.06) |
| Mar'25 | 40.14 (▼0.09) | 20.61 (▼0.17) | 22.95 (▲0.99) | 11.46 (▼0.53) | 0.50 (▼0.16) |
| Dec'24 | 40.23 | 20.78 | 21.96 | 11.99 | 0.66 |
Offsetting the promoter stake reduction, mutual funds emerged as aggressive buyers, increasing their collective holding by 6.25 percentage points to 30.66%, now matching the promoter stake almost exactly. This institutional accumulation by 39 different mutual fund schemes suggests professional investors view the current valuation as attractive, potentially anticipating margin recovery or strategic developments not yet reflected in the stock price. Insurance companies similarly increased their stake by 1.42 percentage points to 13.76%, whilst foreign institutional investors added 1.27 percentage points to reach 19.79%.
The combined institutional holding (FII, mutual funds, insurance, and other DII) now stands at 65.04%, representing strong institutional conviction despite near-term operational challenges. However, the promoter stake reduction from over 40% to just above 30% in a single quarter represents a significant shift in ownership structure that warrants close monitoring for potential implications on corporate governance and strategic direction.
Stock Performance: Underperformance Reflects Margin Concerns
Mphasis shares have significantly underperformed broader market indices across most timeframes, with the stock delivering a negative return of 5.36% over the past year compared to the Sensex's gain of 8.52%, resulting in negative alpha of 13.88 percentage points. The underperformance has accelerated in recent months, with the stock declining 14.57% over the past month against a Sensex decline of just 1.20%, translating to negative alpha of 13.37 percentage points.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -5.97% | -1.14% | -4.83% |
| 1 Month | -14.57% | -1.20% | -13.37% |
| 3 Months | -12.94% | -2.19% | -10.75% |
| 6 Months | -8.90% | +2.59% | -11.49% |
| YTD | -12.06% | -3.04% | -9.02% |
| 1 Year | -5.36% | +8.52% | -13.88% |
| 2 Years | -6.70% | +15.47% | -22.17% |
| 3 Years | +15.23% | +36.73% | -21.50% |
The technical picture has deteriorated markedly, with the stock classified as "mildly bearish" since February 4, 2026, when the trend changed at ₹2,689.55. The stock currently trades below all major moving averages, including the 5-day (₹2,575.71), 20-day (₹2,731.82), 50-day (₹2,807.18), 100-day (₹2,791.87), and 200-day (₹2,752.33) averages, indicating persistent selling pressure and lack of technical support.
Relative to the broader IT services sector, which declined 23.32% over the past year, Mphasis has outperformed by 17.96 percentage points, suggesting company-specific factors are relatively favourable compared to sector-wide headwinds. However, this relative outperformance provides limited comfort given the absolute negative returns and deteriorating momentum indicators.
Investment Thesis: Quality Company Facing Cyclical Headwinds
Mphasis presents a mixed investment proposition characterised by solid fundamental quality metrics undermined by near-term operational challenges and expensive valuation. The company's proprietary investment score of 44 out of 100 places it in the "SELL" category, reflecting concerns about valuation sustainability, margin trajectory, and growth momentum despite underlying business quality.
The company's quality grade of "GOOD" acknowledges its debt-free balance sheet, consistent profitability, average ROCE of 29.84%, and zero promoter pledging. However, the downgrade from "EXCELLENT" quality in prior periods reflects moderating return metrics and slower growth rates, with 5-year sales CAGR of 9.97% and EBIT CAGR of 8.77% representing pedestrian expansion for a mid-cap IT services company.
The valuation grade of "EXPENSIVE" has persisted since July 2025, with the PEG ratio of 2.52x signalling stretched multiples relative to growth prospects. Combined with a "FLAT" financial trend classification for Q3 FY26 and "MILDLY BEARISH" technical trend, the investment thesis leans decidedly negative in the near term, despite the company's solid long-term track record and institutional following.
Key Strengths & Risk Factors
KEY STRENGTHS
- Debt-free balance sheet with net cash position of ₹986 crores as of March 2025, providing financial flexibility and resilience
- Strong institutional holding at 65.04%, indicating professional investor confidence in long-term prospects
- Healthy return on equity averaging 20.32% over recent years, demonstrating efficient capital deployment
- Consistent dividend payer with 63.65% payout ratio and 2.32% dividend yield, providing income cushion for investors
- Zero promoter pledging, eliminating governance concerns related to leveraged promoter holdings
- Revenue momentum with 12.39% year-on-year growth in Q3 FY26, outpacing sector averages
- Strong ROCE averaging 29.84%, indicating superior returns on capital employed relative to cost of capital
KEY CONCERNS
- Sequential profit decline of 5.73% in Q3 FY26 despite revenue growth, highlighting margin compression challenges
- Operating margin contraction to 18.78% from 19.04% year-on-year, indicating pricing pressure or cost inflation
- PAT margin deterioration of 97 basis points sequentially from 12.02% to 11.05%, eroding profitability
- Expensive valuation with PEG ratio of 2.52x, suggesting limited upside potential at current multiples
- Dramatic 9.51 percentage point promoter stake reduction in single quarter, raising questions about insider confidence
- Mildly bearish technical trend with stock trading below all major moving averages, indicating weak momentum
- Modest long-term growth with 5-year sales CAGR of 9.97% and EBIT CAGR of 8.77%, lagging industry leaders
Outlook: Margin Recovery Critical for Re-Rating
The forward outlook for Mphasis hinges critically on the company's ability to arrest margin deterioration and demonstrate sustainable profitability expansion. With operating margins contracting both sequentially and year-on-year despite robust revenue growth, investors will scrutinise upcoming quarters for evidence of operational leverage returning and cost management effectiveness improving.
POSITIVE CATALYSTS
- Margin stabilisation or expansion in Q4 FY26, demonstrating operational efficiency improvements
- Continued institutional accumulation, particularly if mutual fund holdings exceed 32-33% threshold
- Strategic clarity on promoter stake reduction and potential corporate actions or partnerships
- Revenue momentum sustaining above 10% year-on-year growth with improving mix towards higher-margin services
- Technical trend reversal above ₹2,700-2,750 resistance zone with sustained volume support
RED FLAGS
- Further sequential margin compression in Q4 FY26, confirming structural profitability challenges
- Additional promoter stake reduction without clear strategic rationale or succession planning
- Revenue growth deceleration below 8-9% year-on-year, indicating loss of competitive positioning
- Stock breaking below ₹2,400 support level on sustained volume, targeting 52-week low of ₹2,025
- Institutional selling by mutual funds or insurance companies, reversing recent accumulation trend
The company's classification as "FLAT" for financial trend in Q3 FY26, combined with expensive valuation and mildly bearish technical trend, suggests limited near-term upside potential unless operational performance improves materially. Investors should monitor Q4 FY26 results closely for signs of margin stabilisation, as continued profitability erosion would likely trigger further valuation derating despite the company's solid fundamental quality metrics.
The Verdict: Quality Company at Wrong Price Point
Score: 44/100
For Fresh Investors: Avoid initiating positions at current levels given expensive valuation (PEG 2.52x), deteriorating margins, and mildly bearish technical trend. Better entry opportunities likely emerge below ₹2,200-2,250 or upon evidence of sustained margin recovery.
For Existing Holders: Consider reducing exposure on rallies towards ₹2,600-2,700 resistance zone. The dramatic promoter stake reduction, sequential profit decline despite revenue growth, and expensive valuation create an unfavourable risk-reward equation. Maintain positions only if conviction exists in multi-quarter margin recovery story.
Fair Value Estimate: ₹2,150-2,250 (12-15% downside from current levels), based on 22-23x P/E applied to normalised earnings and sector median valuation multiples.
Mphasis remains a fundamentally sound business with debt-free balance sheet, healthy ROE, and strong institutional backing, but the combination of margin compression, expensive valuation, promoter stake reduction, and weak technical setup creates multiple headwinds for near-term performance. The investment thesis improves materially only upon evidence of sustainable margin recovery or significant valuation correction that better reflects the company's moderate growth profile and cyclical margin pressures.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
